Titre : JNK Mitogen-Activated Protein Kinases

JNK Mitogen-Activated Protein Kinases : Questions médicales fréquentes

Termes MeSH sélectionnés :

DNA Copy Number Variations
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "JNK Mitogen-Activated Protein Kinases : Questions médicales les plus fréquentes", "headline": "JNK Mitogen-Activated Protein Kinases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les JNK Mitogen-Activated Protein Kinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-10", "dateModified": "2025-02-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "JNK Mitogen-Activated Protein Kinases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Mitogen-Activated Protein Kinases", "url": "https://questionsmedicales.fr/mesh/D020928", "about": { "@type": "MedicalCondition", "name": "Mitogen-Activated Protein Kinases", "code": { "@type": "MedicalCode", "code": "D020928", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.563.567" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mitogen-Activated Protein Kinase 8", "alternateName": "Mitogen-Activated Protein Kinase 8", "url": "https://questionsmedicales.fr/mesh/D048055", "about": { "@type": "MedicalCondition", "name": "Mitogen-Activated Protein Kinase 8", "code": { "@type": "MedicalCode", "code": "D048055", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.563.567.374.500" } } }, { "@type": "MedicalWebPage", "name": "Mitogen-Activated Protein Kinase 9", "alternateName": "Mitogen-Activated Protein Kinase 9", "url": "https://questionsmedicales.fr/mesh/D048056", "about": { "@type": "MedicalCondition", "name": "Mitogen-Activated Protein Kinase 9", "code": { "@type": "MedicalCode", "code": "D048056", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.563.567.374.750" } } }, { "@type": "MedicalWebPage", "name": "Mitogen-Activated Protein Kinase 10", "alternateName": "Mitogen-Activated Protein Kinase 10", "url": "https://questionsmedicales.fr/mesh/D048057", "about": { "@type": "MedicalCondition", "name": "Mitogen-Activated Protein Kinase 10", "code": { "@type": "MedicalCode", "code": "D048057", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.563.567.374.800" } } } ], "about": { "@type": "MedicalCondition", "name": "JNK Mitogen-Activated Protein Kinases", "alternateName": "JNK Mitogen-Activated Protein Kinases", "code": { "@type": "MedicalCode", "code": "D048031", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mohammad Shafiq", "url": "https://questionsmedicales.fr/author/Mohammad%20Shafiq", "affiliation": { "@type": "Organization", "name": "From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India." } }, { "@type": "Person", "name": "Kumaravelu Jagavelu", "url": "https://questionsmedicales.fr/author/Kumaravelu%20Jagavelu", "affiliation": { "@type": "Organization", "name": "From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India." } }, { "@type": "Person", "name": "Neeraj Kumar Verma", "url": "https://questionsmedicales.fr/author/Neeraj%20Kumar%20Verma", "affiliation": { "@type": "Organization", "name": "Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India." } }, { "@type": "Person", "name": "Jimut Kanti Ghosh", "url": "https://questionsmedicales.fr/author/Jimut%20Kanti%20Ghosh", "affiliation": { "@type": "Organization", "name": "Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India." } }, { "@type": "Person", "name": "Matthias Gaestel", "url": "https://questionsmedicales.fr/author/Matthias%20Gaestel", "affiliation": { "@type": "Organization", "name": "Institute for Zellbiochemie, Medizinische Hochschule Hannover (MHH), Hanover, Germany (M.G.)." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Copy-number analysis by base-level normalization: An intuitive visualization tool for evaluating copy number variations.", "datePublished": "2022-10-03", "url": "https://questionsmedicales.fr/article/36152294", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cge.14236" } }, { "@type": "ScholarlyArticle", "name": "Multiple copy number variation in a patient with Kleefstra syndrome.", "datePublished": "2023-09-15", "url": "https://questionsmedicales.fr/article/37729241", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1984-0462/2024/42/2022230" } }, { "@type": "ScholarlyArticle", "name": "Clinical Findings on Chromosome 1 Copy Number Variations.", "datePublished": "2022-07-14", "url": "https://questionsmedicales.fr/article/35835157", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/s-0042-1754162" } }, { "@type": "ScholarlyArticle", "name": "Copy Number Variation among Resistance Genes Analogues in", "datePublished": "2022-11-04", "url": "https://questionsmedicales.fr/article/36360273", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/genes13112037" } }, { "@type": "ScholarlyArticle", "name": "A crowdsourcing database for the copy-number variation of the Spanish population.", "datePublished": "2023-03-09", "url": "https://questionsmedicales.fr/article/36894999", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40246-023-00466-8" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines et peptides de signalisation intracellulaire", "item": "https://questionsmedicales.fr/mesh/D047908" }, { "@type": "ListItem", "position": 5, "name": "Protein-Serine-Threonine Kinases", "item": "https://questionsmedicales.fr/mesh/D017346" }, { "@type": "ListItem", "position": 6, "name": "Mitogen-Activated Protein Kinases", "item": "https://questionsmedicales.fr/mesh/D020928" }, { "@type": "ListItem", "position": 7, "name": "JNK Mitogen-Activated Protein Kinases", "item": "https://questionsmedicales.fr/mesh/D048031" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : JNK Mitogen-Activated Protein Kinases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur JNK Mitogen-Activated Protein Kinases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur JNK Mitogen-Activated Protein Kinases", "description": "Comment diagnostiquer une activation des JNK ?\nQuels biomarqueurs indiquent l'activation des JNK ?\nLes tests génétiques sont-ils utiles pour les JNK ?\nQuels examens d'imagerie sont utilisés pour les JNK ?\nPeut-on mesurer l'activité des JNK dans le sang ?", "url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=DNA+Copy+Number+Variations&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur JNK Mitogen-Activated Protein Kinases", "description": "Quels symptômes sont liés à l'activation des JNK ?\nLes JNK sont-ils impliqués dans des maladies ?\nComment les JNK affectent-ils la douleur ?\nLes JNK influencent-ils le métabolisme ?\nY a-t-il des symptômes neurologiques associés aux JNK ?", "url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=DNA+Copy+Number+Variations&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur JNK Mitogen-Activated Protein Kinases", "description": "Comment prévenir l'activation des JNK ?\nLe stress influence-t-il les JNK ?\nLes antioxydants aident-ils à prévenir l'activation des JNK ?\nL'exercice physique prévient-il l'activation des JNK ?\nLes habitudes alimentaires influencent-elles les JNK ?", "url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=DNA+Copy+Number+Variations&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur JNK Mitogen-Activated Protein Kinases", "description": "Quels traitements ciblent les JNK ?\nLes anti-inflammatoires affectent-ils les JNK ?\nLa thérapie génique peut-elle cibler les JNK ?\nLes traitements naturels influencent-ils les JNK ?\nLes traitements anticancéreux ciblent-ils les JNK ?", "url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=DNA+Copy+Number+Variations&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur JNK Mitogen-Activated Protein Kinases", "description": "Quelles complications sont liées à l'activation des JNK ?\nLes JNK sont-ils liés à des complications cardiovasculaires ?\nLes JNK influencent-ils le vieillissement cellulaire ?\nY a-t-il des complications neurologiques liées aux JNK ?\nLes JNK sont-ils impliqués dans des complications métaboliques ?", "url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=DNA+Copy+Number+Variations&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur JNK Mitogen-Activated Protein Kinases", "description": "Quels facteurs de risque influencent les JNK ?\nL'alimentation affecte-t-elle les JNK ?\nLe tabagisme influence-t-il les JNK ?\nL'exposition à des toxines affecte-t-elle les JNK ?\nLe manque d'exercice est-il un facteur de risque pour les JNK ?", "url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=DNA+Copy+Number+Variations&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une activation des JNK ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de signalisation cellulaire et des analyses protéomiques peuvent être utilisés." } }, { "@type": "Question", "name": "Quels biomarqueurs indiquent l'activation des JNK ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de protéines phosphorylées c-Jun peuvent indiquer une activation." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour les JNK ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests peuvent identifier des mutations affectant la voie JNK." } }, { "@type": "Question", "name": "Quels examens d'imagerie sont utilisés pour les JNK ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie par résonance magnétique peut aider à visualiser des effets cellulaires." } }, { "@type": "Question", "name": "Peut-on mesurer l'activité des JNK dans le sang ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des échantillons sanguins peuvent être analysés pour des marqueurs d'activation." } }, { "@type": "Question", "name": "Quels symptômes sont liés à l'activation des JNK ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "L'activation peut entraîner inflammation, apoptose et dysfonction cellulaire." } }, { "@type": "Question", "name": "Les JNK sont-ils impliqués dans des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont associés à des maladies comme le cancer et les maladies neurodégénératives." } }, { "@type": "Question", "name": "Comment les JNK affectent-ils la douleur ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils modulent la signalisation de la douleur, contribuant à des douleurs chroniques." } }, { "@type": "Question", "name": "Les JNK influencent-ils le métabolisme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils jouent un rôle dans la régulation du métabolisme énergétique." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés aux JNK ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles cognitifs et des troubles de l'humeur peuvent être observés." } }, { "@type": "Question", "name": "Comment prévenir l'activation des JNK ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider." } }, { "@type": "Question", "name": "Le stress influence-t-il les JNK ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress oxydatif peut activer les JNK, donc la gestion du stress est cruciale." } }, { "@type": "Question", "name": "Les antioxydants aident-ils à prévenir l'activation des JNK ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antioxydants peuvent réduire le stress oxydatif et l'activation des JNK." } }, { "@type": "Question", "name": "L'exercice physique prévient-il l'activation des JNK ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut moduler positivement l'activité des JNK." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles les JNK ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en nutriments peut réduire l'activation des JNK." } }, { "@type": "Question", "name": "Quels traitements ciblent les JNK ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des inhibiteurs spécifiques des JNK sont en développement pour diverses maladies." } }, { "@type": "Question", "name": "Les anti-inflammatoires affectent-ils les JNK ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains anti-inflammatoires peuvent moduler l'activité des JNK." } }, { "@type": "Question", "name": "La thérapie génique peut-elle cibler les JNK ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est explorée pour corriger des dysfonctionnements des JNK." } }, { "@type": "Question", "name": "Les traitements naturels influencent-ils les JNK ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certaines plantes médicinales peuvent avoir un effet sur l'activation des JNK." } }, { "@type": "Question", "name": "Les traitements anticancéreux ciblent-ils les JNK ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements anticancéreux visent à inhiber les voies JNK dans les cellules tumorales." } }, { "@type": "Question", "name": "Quelles complications sont liées à l'activation des JNK ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "L'activation excessive des JNK peut entraîner des maladies inflammatoires et cancéreuses." } }, { "@type": "Question", "name": "Les JNK sont-ils liés à des complications cardiovasculaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'activation des JNK est associée à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les JNK influencent-ils le vieillissement cellulaire ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une activation prolongée des JNK peut accélérer le vieillissement cellulaire." } }, { "@type": "Question", "name": "Y a-t-il des complications neurologiques liées aux JNK ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'activation des JNK est impliquée dans des troubles neurodégénératifs." } }, { "@type": "Question", "name": "Les JNK sont-ils impliqués dans des complications métaboliques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont liés à des troubles métaboliques comme le diabète." } }, { "@type": "Question", "name": "Quels facteurs de risque influencent les JNK ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le stress, l'inflammation chronique et l'obésité sont des facteurs de risque connus." } }, { "@type": "Question", "name": "L'alimentation affecte-t-elle les JNK ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées peut augmenter l'activation des JNK." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il les JNK ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque qui peut activer les JNK." } }, { "@type": "Question", "name": "L'exposition à des toxines affecte-t-elle les JNK ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines environnementales peut activer les JNK." } }, { "@type": "Question", "name": "Le manque d'exercice est-il un facteur de risque pour les JNK ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire peut augmenter le risque d'activation des JNK." } } ] } ] }

Sources (10000 au total)

Multiple copy number variation in a patient with Kleefstra syndrome.

To report a rare case of a patient with a molecular diagnosis of Kleefstra syndrome (KS) who has four other chromosomal alterations involving pathogenic variants.... Male patient, two years old, with global delay, including in neuropsychomotor development, ocular hypertelorism, broad forehead, brachycephaly, hypotonia, ligament laxity, unilateral single palmar cre... The presence of pathogenic CNVs and/or those of uncertain significance, located on chromosomes 2, 6 and Y, may be contributing to a variability in the patient's clinical condition (arachnoid cyst, sin...

A crowdsourcing database for the copy-number variation of the Spanish population.

Despite being a very common type of genetic variation, the distribution of copy-number variations (CNVs) in the population is still poorly understood. The knowledge of the genetic variability, especia... Here, we present the SPAnish Copy Number Alterations Collaborative Server (SPACNACS), which currently contains copy number variation profiles obtained from more than 400 genomes and exomes of unrelate... SPACNACS facilitates disease gene discovery by providing detailed information of the local variability of the population and exemplifies how to reuse genomic data produced for other purposes to build ...

Association between clinical variations and copy number variations in cases with Turner syndrome.

Turner syndrome (TS) is one of the most common chromosomal abnormalities with an incidence of approximately one in 2,500 live births. Short stature and primary ovarian insufficiency are two most impor... Fifty-three patients diagnosed with TS, between the ages of 0-18 were included in the study. Peripheral blood samples were taken from 36 cases for microarray study.... Karyotypes were as follows: thirty-three of cases were 45,X, 7 were 45,X/46,XX, 6 were 45,X/46,Xi(Xq), 2 were 46,Xi(Xq), 2 were 45,X/46,r(X), 1 was 45,X/46,Xi(Xp), 1 was 45,X/46,XY and 1 was 45,X/46,X... In conclusion, the microarray method has a great contribution in explaining many unexpected findings in TS cases. Moreover, those CNV findings may contribute for the explanation of the underlying mech...

A comprehensive analysis of copy number variations in diverse apple populations.

As an important source of genetic variation, copy number variation (CNV) can alter the dosage of DNA segments, which in turn may affect gene expression level and phenotype. However, our knowledge of C... In this study, we identified 914,610 CNVs comprising 14,839 CNV regions (CNVRs) from 346 apple accessions, including 289 cultivars and 57 wild relatives. CNVRs summed to 71.19 Mb, accounting for 10.03... This study was based on identification of CNVs from 346 diverse apple accessions, which to our knowledge was the largest dataset for CNV analysis in apple. Our work presented the first comprehensive C...

Analysis of copy number variation in men with non-obstructive azoospermia.

Recent findings demonstrate that single nucleotide variants can cause non-obstructive azoospermia (NOA). In contrast, copy number variants (CNVs) were only analysed in few studies in infertile men. So... This study aimed to elucidate if CNVs are associated with NOA.... We performed array-based comparative genomic hybridisation (aCGH) in 37 men with meiotic arrest, 194 men with Sertoli cell-only phenotype, and 21 control men. We filtered our data for deletions affect... We determined the cause of infertility in two individuals with homozygous deletions of SYCE1 and in one individual with a heterozygous deletion of SYCE1 combined with a likely pathogenic missense vari... While SYCE1 and MLH3 encode known meiosis-specific proteins, much less is known about the proteins encoded by the other identified candidate genes, warranting further analyses. We were able to identif... As aCGH and exome sequencing are both expensive methods, combining both in a clinical routine is not an effective strategy. Instead, using CNV calling from exome data has recently become more precise,...